Daron Acemoglu in Project Syndicate:
According to tech leaders and many pundits and academics, artificial intelligence is poised to transform the world as we know it through unprecedented productivity gains. While some believe that machines soon will do everything humans can do, ushering in a new age of boundless prosperity, other predictions are at least more grounded. For example, Goldman Sachs predicts that generative AI will boost global GDP by 7% over the next decade, and the McKinsey Global Institute anticipates that the annual GDP growth rate could increase by 3-4 percentage points between now and 2040. For its part, The Economist expects that AI will create a blue-collar bonanza.
Is this realistic? As I note in a recent paper, the outlook is far more uncertain than most forecasts and guesstimates suggest. Still, while it is basically impossible to predict with any confidence what AI will do in 20 or 30 years, one can say something about the next decade, because most of these near-term economic effects must involve existing technologies and improvements to them.
It is reasonable to suppose that AI’s biggest impact will come from automating some tasks and making some workers in some occupations more productive. Economic theory provides some guidance for assessing these aggregate effects. According to Hulten’s theorem (named for economist Charles Hulten), aggregate “total factor productivity” (TFP) effects are simply the product of the share of tasks that are automated multiplied by the average cost savings.
While average cost savings are difficult to estimate and will vary by activity, there have already been some careful studies of AI’s effects on certain tasks.
Enjoying the content on 3QD? Help keep us going by donating now.



Three times a day my phone pings with a notification telling me that I have a new happiness survey to take. The survey, from
How could gaining knowledge amount to anything other than discovering what was already there? How could the truth of a statement or a theory be anything but its correspondence to facts that were fixed before we started investigating them?
Writers are those naïfs among us who believe that language can be used to take the measure of experience. Readers demonstrate faith in them when they commit to a book or short story. The reader-writer relationship is a contract of sorts. But because the terms are not written down, there is much room in that contract for misinterpretation. What is at stake is not small: it is a shared picture of reality. Nor is it static. With each new publication or rereading, the reader-writer contract is up for review. What could go wrong?
W
I do not think that being mean is a virtue, but it is related to the virtue by means of which we tell the truth. There are other ways of telling the truth. We can be circumspect or ironic—there is very often a nicer way to put something. Yet there are good reasons for sometimes being just a little bit mean. (No, I am not thinking about that gratuitously nasty and rebarbative character now dominating our public realm.) I think of being mean the way that the King of Brobdingnag in Gulliver’s Travels talks about dangerous views: “For a man may be allowed to keep poisons in his closet, but not to vend them about for cordials.” That is to say, I think being nice is required for good politics, but being mean has definite social utility in private life—and it should stay there.
Robotic vehicles can
One of the core assumptions of modern liberalism is that if you can solve the problem of material scarcity, you can go a long way to solving the problem of free and peaceful coexistence among equals. Modern technology has been essential to that dynamic from the start, a key driver of “development” and the success of democratic regimes. The West, and large parts of the rest of the world, are what they are today in great measure due to this project.
A newly developed blood test for
If you hear the word Ozempic, weight loss immediately comes to mind. The drug—part of a family of treatments called GLP-1 agonists—took the medical world (and internet) by storm for helping people manage diabetes, lower the risk of heart disease, and rapidly lose weight. The drugs may also protect the brain against dementia. In a clinical trial including over 200 people with mild Alzheimer’s disease, a daily injection of a GLP-1 drug for one year slowed cognitive decline. When challenged with a battery of tests assessing memory, language skills, and decision-making, participants who took the drug remained sharper for longer than those who took a placebo—an injection that looked the same but wasn’t functional. The results are the latest from the
There’s no question that we love to talk — but how did it happen? Yes, humpback whales sing, vervet monkeys use alarm calls, and bees convey information about food sources through dance, but